Machine learning approaches for the mortality risk assessment of patients undergoing hemodialysis.

Authors:
Yang CH; Chen YS; Moi SH; Chen JB; Wang L and 1 more

Journal:
Ther Adv Chronic Dis

Publication Year: 2022

DOI:
10.1177/20406223221119617

PMCID:
PMC9434675

PMID:
36062293

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ther Adv Chronic Dis

Abbreviation: Ther Adv Chronic Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Aortic arch calcification increases major adverse cardiac event risk, modifiable by echocardiograph…
Chao CT; Liao MT; Wu CK. (2024) - Transparency Score: 3/6
Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnosti…
Conigliaro P; D'Antonio A; Wlderk A and 7 more (2024) - Transparency Score: 3/6
Epidemiological characteristics, etiological spectrum, and outcomes of adult patients with pericard…
Farah Yusuf Mohamud M; Abdi IA; Uzel M and 5 more (2024) - Transparency Score: 3/6
Photodynamic therapy of cervical cancer: a scoping review on the efficacy of various molecules.
Shanazarov NA; Zare A; Mussin NM and 5 more (2024) - Transparency Score: 3/6
Prevalence of major non-communicable diseases and their associated risk factors in Afghanistan: a s…
Noormal AS; Winkler V; Bhusari SB and 8 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

Evidence found in paper:

"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was partly supported by the National Science and Technology Council, R.O.C. (111-2221-E-165-001-MY3), Taiwan."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025